10-Q: SCWorx Corp. Reports Q3 2024 Results with Revenue Decline and Reduced Operating Expenses

SCWorx Corp. experienced a decrease in revenue and a net loss for the third quarter of 2024, while also reducing operating expenses.

Summary

• SCWorx Corp. reported a revenue of $759,724 for the three months ended September 30, 2024, a decrease from $906,099 in the same period of 2023.
• The company's cost of revenue decreased to $627,148 from $666,808 year-over-year.
• Operating expenses were significantly reduced to $526,074, compared to $1,097,273 in the prior year's quarter.
• The net loss for the quarter was $424,963, an improvement from the $858,258 loss in the third quarter of 2023.
• For the nine months ended September 30, 2024, revenue was $2,313,850, down from $2,894,647 in 2023.
• The net loss for the nine-month period was $940,935, compared to a net loss of $1,412,070 in the same period of 2023.
• The company's cash balance was $87,666 as of September 30, 2024, down from $91,436 at the end of 2023.
• SCWorx has an accumulated deficit of $30,780,776 as of September 30, 2024.
• The company issued convertible notes totaling $1,155,000 in July 2024, with a conversion price of $1.43 per share.

Sentiment

Score: 3

Explanation: The document indicates a struggling company with declining revenue, ongoing losses, and concerns about its ability to continue as a going concern. While there are some improvements in net loss and operating expenses, the overall outlook is negative.

Positives

• The company significantly reduced operating expenses in both the three and nine month periods ending September 30, 2024.
• The net loss improved in both the three and nine month periods ending September 30, 2024 compared to the same periods in 2023.
• The company secured $1,155,000 in convertible note financing in July 2024.

Negatives

• Revenue decreased in both the three and nine month periods ending September 30, 2024, primarily due to the expiration of customer contracts.
• The company continues to experience net losses and has an accumulated deficit of $30,780,776.
• The company's cash balance is low at $87,666 as of September 30, 2024.
• The company's auditors have raised concerns about the company's ability to continue as a going concern.

Risks

• The company faces the risk of not being able to reverse the recent decline in revenue and resume growth.
• There are ongoing litigation proceedings that could have an adverse impact on the company.
• The company may not be able to obtain additional financing in sufficient amounts or on acceptable terms.
• The company is dependent on third-party subcontractors to perform some of the work on its contracts.
• Changes in laws, regulations, or industry standards could adversely affect the company's ability to conduct business.
• The company's customers may delay payments due to the financial impact of COVID-19.
• The company's internal controls are not effective.

Future Outlook

The company expects operating expenses to remain relatively flat during the rest of 2024. The company is evaluating various alternatives, including reducing operating expenses, securing additional financing through debt or equity securities to fund future business activities and other strategic alternatives.

Management Comments

• Management believes that the company's customers were not able to focus resources on expanding the utilization of the company's services due to the COVID-19 pandemic.
• Management has concluded that conditions exist that raise substantial doubt about the company's ability to continue as a going concern.
• Management is evaluating various alternatives, including reducing operating expenses, securing additional financing through debt or equity securities to fund future business activities and other strategic alternatives.

Industry Context

The company operates in the healthcare information technology sector, providing data content and services related to data normalization and interoperability. The COVID-19 pandemic has significantly impacted the healthcare industry, causing disruptions to hospitals and their supply chains, which has affected the company's customer acquisition and revenue.

Comparison to Industry Standards

• It is difficult to make a direct comparison to industry standards without more specific information on the company's peer group.
• However, the company's revenue decline and net losses are concerning and suggest that it is underperforming compared to other established companies in the healthcare IT sector.
• The company's reliance on third-party subcontractors and its ongoing litigation issues are also potential weaknesses compared to industry best practices.
• The company's cash position is very low compared to other companies in the sector.

Legal Proceedings

• The company is involved in ongoing legal proceedings, including the Core IR arbitration case, the Hadrian Equities Partners, LLC lawsuit, and the Carole R. Bernstein, Esq. lawsuit.
• The company has entered into settlement agreements in the Core IR and Hadrian Equities Partners, LLC cases, involving cash payments and the issuance of common stock.
• The company has also entered into a settlement agreement with Carole R. Bernstein, Esq. involving cash payments.

Related Party Transactions

• The company has a payable due to an officer in the amount of $149,838 for contract work performed prior to becoming an officer.
• The company had a shareholder advance of $67,622 as of September 30, 2024.
• The company's CFO advanced an aggregate $128,479 in cash to the company for short term capital requirements, which has been repaid as of September 30, 2024.

Stakeholder Impact

• Shareholders are at risk of losing their investment due to the company's financial difficulties and the potential for the company to fail.
• Employees may be affected by potential cost-cutting measures and the uncertainty surrounding the company's future.
• Customers may be concerned about the company's ability to continue providing services.
• Creditors may be at risk of not being repaid if the company's financial situation does not improve.

Next Steps

• The company is evaluating various alternatives, including reducing operating expenses.
• The company is seeking additional financing through debt or equity securities.
• The company needs to address the ongoing litigation proceedings.
• The company needs to improve its internal controls.

Key Dates

Keywords

healthcare, data normalization, interoperability, SaaS, software, revenue, net loss, operating expenses, convertible notes, litigation, financial results, going concern